TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 54 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $12,660,000 | +4.7% | 13,285,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $12,095,000 | -1.0% | 13,285,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $12,214,000 | -0.8% | 13,285,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $12,314,000 | +2.1% | 13,285,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $12,056,000 | -3.5% | 13,285,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $12,491,000 | +0.9% | 13,285,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $12,380,000 | +5.7% | 13,285,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $11,710,000 | – | 13,285,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Southpaw Asset Management LP | 20,000,000 | $17,675,000 | 25.38% |
| INCOME RESEARCH & MANAGEMENT | 23,109,000 | $20,278,000 | 5.29% |
| Fore Capital, LLC | 5,000,000 | $4,430,000 | 1.71% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 20,000,000 | $17,603,000 | 0.74% |
| ARISTEIA CAPITAL, L.L.C. | 18,500,000 | $16,361,000 | 0.70% |
| ZAZOVE ASSOCIATES LLC | 11,153,000 | $9,843,000 | 0.58% |
| BASSO CAPITAL MANAGEMENT, L.P. | 3,600,000 | $3,182,000 | 0.52% |
| CSS LLC/IL | 10,450,000 | $9,240,000 | 0.45% |
| Lombard Odier Asset Management (Europe) Ltd | 7,950,000 | $7,038,000 | 0.44% |
| Wellesley Asset Management | 6,740 | $5,948,000 | 0.31% |